Is 13K undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6
Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 13K when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 13K (€10.7) is trading above our estimate of fair value (€10.02)
Significantly Below Fair Value: 13K is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 13K?
Key metric: As 13K is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
The above table shows the Price to Sales ratio for 13K. This is calculated by dividing 13K's market cap by their current
revenue.
What is 13K's PS Ratio?
PS Ratio
3.3x
Sales
US$483.20m
Market Cap
US$1.58b
13K key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Sales vs Industry: 13K is good value based on its Price-To-Sales Ratio (3.3x) compared to the German Real Estate industry average (3.8x).
Price to Sales Ratio vs Fair Ratio
What is 13K's PS Ratio
compared to its
Fair PS Ratio?
This is the expected PS Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
13K PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio
3.3x
Fair PS Ratio
n/a
Price-To-Sales vs Fair Ratio: Insufficient data to calculate 13K's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
The above table shows the analyst 13K forecast and predictions for the stock price in 12 month’s time.
Date
Share Price
Average 1Y Price Target
Dispersion
High
Low
1Y Actual price
Analysts
Current
€10.70
€10.88
+1.6%
13.5%
€12.35
€9.40
n/a
2
Nov ’25
€9.65
€9.65
+0.03%
21.5%
€11.73
€7.58
n/a
2
Oct ’25
€9.55
€9.65
+1.1%
21.5%
€11.73
€7.58
n/a
2
Sep ’25
€9.85
€9.65
-2.0%
21.5%
€11.73
€7.58
n/a
2
Aug ’25
€9.45
€9.47
+0.2%
17.6%
€11.14
€7.80
n/a
2
Jul ’25
€8.90
€9.47
+6.4%
17.6%
€11.14
€7.80
n/a
2
Jun ’25
€9.25
€9.47
+2.4%
17.6%
€11.14
€7.80
n/a
2
May ’25
€7.90
€9.33
+18.1%
28.7%
€12.01
€6.65
n/a
2
Apr ’25
€7.80
€9.33
+19.7%
28.7%
€12.01
€6.65
n/a
2
Mar ’25
€7.95
€9.33
+17.4%
28.7%
€12.01
€6.65
n/a
2
Feb ’25
€9.30
€10.86
+16.7%
37.9%
€14.97
€6.74
n/a
2
Jan ’25
€11.10
€10.86
-2.2%
37.9%
€14.97
€6.74
n/a
2
Dec ’24
€10.60
€10.86
+2.4%
37.9%
€14.97
€6.74
n/a
2
Jun ’24
€14.10
€16.64
+18.0%
2.6%
€17.25
€16.34
€9.25
3
May ’24
€15.00
€17.52
+16.8%
4.3%
€18.44
€16.59
€7.90
3
Apr ’24
€15.00
€17.52
+16.8%
4.3%
€18.44
€16.59
€7.80
3
Mar ’24
€15.40
€18.55
+20.5%
2.4%
€18.86
€17.92
€7.95
3
Feb ’24
€16.10
€18.35
+14.0%
8.8%
€19.94
€16.14
€9.30
3
Jan ’24
€14.50
€18.35
+26.6%
8.8%
€19.94
€16.14
€11.10
3
Dec ’23
€16.00
€19.31
+20.7%
8.7%
€20.27
€16.41
€10.60
4
Nov ’23
€16.80
€22.31
+32.8%
12.4%
€25.35
€18.25
€12.00
4
Analyst Forecast: Target price is lower than the current share price.